OTC Markets EXMKT - Delayed Quote USD

China Health Industries Holdings, Inc. (CHHE)

0.2001
+0.2001
(0.00%)
At close: May 9 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Sun Xin Chairman, CEO, CFO & Treasurer 12.52k -- 1966

China Health Industries Holdings, Inc.

3199-1 Longxiang Road
Songbei District
Harbin, 150028
China
86 451 8810 0688 https://www.chinahealthindustries.com
Sector: 
Healthcare
Full Time Employees: 
32

Description

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.

Corporate Governance

China Health Industries Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 14, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

September 30, 2024 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

September 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 26, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 16, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

May 15, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

April 1, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 15, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

January 19, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission